Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study
Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study ab...
Saved in:
Published in | Medicine (Baltimore) Vol. 96; no. 26; p. e7285 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved
01.06.2017
Wolters Kluwer Health |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread. |
---|---|
AbstractList | Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread.Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread. Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it.A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010.The tumors were diagnosed late (70.3% stage III-IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11-7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02-3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12-2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23-2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%.Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread. Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but there is no detailed data in the French general population to fuel the public health debate on it. A high-resolution population-based study about cancer management was conducted, using cancers registries in the north-west of France, on 1729 tumors diagnosed between 2008 and 2010. The tumors were diagnosed late (70.3% stage III–IV), mainly after the onset of symptoms (93.2%). After adjustment, advanced stages were more frequent in patients with hypopharyngeal [adjusted odds ratio (ORa): 4.68; 95% confidence interval [CI] 3.11–7.05] and oropharyngeal tumors (ORa: 2.84; 95% CI 2.02–3.99) compared with oral cavity ones. They were also more frequent in patients with moderate (ORa 1.68; 95% CI 1.12–2.52) or severe comorbidities (ORa 1.86; 95% CI: 1.23–2.80). A multidisciplinary meeting (MM) had taken place in 96.9% of cases. The assessment included a panendoscopy in 80.3% of cases, a cervical computerized tomography (CT) scan in 89.3% and a chest CT scan in 87.3%. The vast majority of patients (90.7%) had received treatment, with surgery in 48.7% of cases and/or radiotherapy in 76.9%. Despite the recommendations for early detection, diagnoses are often made late, even for tumors that can be detected by a direct visual and tactile examination of the oral cavity. However, the major risk of advanced stage concerns deep tumors and the most weakened subjects. Otherwise, diagnostic assessment is broadly consistent with the recommendations, and multidisciplinary treatment decisions are widespread. |
Author | Dejardin, Olivier J. Ligier, Karine A. Lapôtre-Ledoux, Bénédicte M. Bara, Simona Launoy, Guy D. Launay, Ludivine C. Guizard, Anne-Valerie N. Babin, Emmanuel B. |
AuthorAffiliation | Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen U1086 Inserm – Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France |
AuthorAffiliation_xml | – name: Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen U1086 Inserm – Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France – name: a Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen – name: d Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville – name: f Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen – name: g Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France – name: b Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen – name: e Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens – name: c U1086 Inserm – Université Caen Basse Normandie |
Author_xml | – sequence: 1 givenname: Anne-Valerie surname: Guizard middlename: N. fullname: Guizard, Anne-Valerie N. organization: Registre général des tumeurs du Calvados, Centre F Baclesse, U1086 Inserm – Université Caen Basse Normandie “Cancers et preventions,” av Général-Harris, Caen Pôle de Recherche, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen U1086 Inserm – Université Caen Basse Normandie Registre des cancers de la Manche, Centre Hospitalier Public du Cotentin, Cherbourg-Octeville Registre du cancer de la Somme, Hôpital Nord, CHU Amiens, Place Victor Pauchet, Amiens Service ORL et chirurgie cervico-faciale, Centre Hospitalo-universitaire de Caen, U1086 Inserm - Université Caen Basse Normandie, “Cancers et préventions”, Centre F Baclesse, av Général-Harris, Caen Registre général des cancers de Lille et sa région, GCS Centre de Référence Régional en Cancérologie, CHRU de LILLE - Hôpital Calmette, Boulevard du Professeur Jules Leclercq, Lille, France – sequence: 2 givenname: Olivier surname: Dejardin middlename: J. fullname: Dejardin, Olivier J. – sequence: 3 givenname: Ludivine surname: Launay middlename: C. fullname: Launay, Ludivine C. – sequence: 4 givenname: Simona surname: Bara fullname: Bara, Simona – sequence: 5 givenname: Bénédicte surname: Lapôtre-Ledoux middlename: M. fullname: Lapôtre-Ledoux, Bénédicte M. – sequence: 6 givenname: Emmanuel surname: Babin middlename: B. fullname: Babin, Emmanuel B. – sequence: 7 givenname: Guy surname: Launoy middlename: D. fullname: Launoy, Guy D. – sequence: 8 givenname: Karine surname: Ligier middlename: A. fullname: Ligier, Karine A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28658124$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9v1DAQxS1URLeFT4CEfOTi4r9xwgGp6lJAasUFztbEcTamib3YSat-e7y7pSq94Iulmd-bsd87QUchBofQW0bPGG30h-v1GX1yNK_VC7RiSlRENZU8QitKuSK60fIYneT8i1ImNJev0DGvK1UzLlcorD1sQsw-YwgdniDAxk0uzDj2eHDQ7cvB2RtsIViXMvYBAx78ZiA-WN-5UsWQHOwal2kHfcTneBu3ywizj4G0kF2H87x096_Ryx7G7N483Kfo5-XnHxdfydX3L98uzq-IlVRxUoNkvVWq0X1LGYeeWgYN51pC3SrphATn-kq3XAJr6qowVFZUKqjB9gDiFH06zN0u7eQ6Wz6UYDTb5CdI9yaCN_92gh_MJt4apYqVsioD3j8MSPH34vJsJp-tG0cILi7ZsIbJWmolREHfPd31uOSvyQUQB8CmmHNy_SPCqNlFaa7X5nmURdU8U1k_7w0tD_bjf7TyoL2L41wyuxmXO5dMyXOchz2udMMJp0zTSlBKSkVw8Qd8O7ID |
CitedBy_id | crossref_primary_10_1186_s12957_024_03407_4 crossref_primary_10_3390_cancers14122968 crossref_primary_10_4102_phcfm_v15i1_3749 crossref_primary_10_1021_acs_bioconjchem_3c00406 crossref_primary_10_1177_00034894221086087 crossref_primary_10_3390_jcm13082439 crossref_primary_10_18632_oncotarget_25284 crossref_primary_10_1007_s11654_023_00501_z crossref_primary_10_1097_MD_0000000000029880 crossref_primary_10_1007_s00405_021_07118_4 crossref_primary_10_3390_jcm12124039 crossref_primary_10_1200_GO_22_00073 crossref_primary_10_1590_1807_3107bor_2023_vol37_0015 crossref_primary_10_17650_1818_8346_2021_16_3_105_117 crossref_primary_10_3166_s11839_017_0634_x crossref_primary_10_1016_j_oraloncology_2022_106278 crossref_primary_10_3892_etm_2022_11291 crossref_primary_10_1097_PPO_0000000000000671 crossref_primary_10_3892_ol_2018_9298 crossref_primary_10_1371_journal_pone_0202897 crossref_primary_10_1016_j_bjorl_2021_04_008 crossref_primary_10_3389_froh_2022_827360 crossref_primary_10_1097_MD_0000000000017472 |
Cites_doi | 10.1002/ijc.29063 10.1093/annonc/mdq185 10.1016/j.oraloncology.2008.10.012 10.1016/j.amepre.2004.07.018 10.1016/j.oooo.2013.12.407 10.1016/0021-9681(87)90171-8 10.1016/j.lpm.2008.03.010 10.1016/j.canep.2010.04.012 10.1016/j.oraloncology.2011.02.013 10.1016/j.oraloncology.2013.10.016 10.1016/j.oraloncology.2004.09.008 10.1016/j.respe.2011.10.006 10.1016/j.ejca.2012.12.027 10.1136/jech-2011-200311 10.1016/j.oraloncology.2004.10.010 |
ContentType | Journal Article |
Copyright | The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved. Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 |
Copyright_xml | – notice: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved. – notice: Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1097/MD.0000000000007285 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1536-5964 |
EndPage | e7285 |
ExternalDocumentID | PMC5500046 28658124 10_1097_MD_0000000000007285 00005792-201706300-00032 |
Genre | Journal Article Observational Study |
GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 354 40H 4Q1 4Q2 4Q3 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAGIX AAHPQ AAIQE AAMOA AAQKA AARTV AASCR AAWTL AAXQO AAYEP ABASU ABBUW ABCQX ABDIG ABFRF ABOCM ABVCZ ABXVJ ABZAD ABZZY ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY ADNKB ADPDF AE6 AEFWE AENEX AFBFQ AFDTB AGOPY AHOMT AHQNM AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BQLVK CS3 DIWNM DU5 E.X EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FD6 FIJ FL- GNXGY GQDEL GROUPED_DOAJ H0~ HLJTE HYE HZ~ H~9 IKREB IKYAY IN~ IPNFZ JK3 JK8 K8S KD2 KMI KQ8 L-C N9A N~7 N~B O9- OAG OAH OB2 OHH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OUVQU OVD OVDNE OVEED OVIDH OVLEI OWV OWW OWZ OXXIT P2P RIG RLZ RPM RXW S4R S4S TAF TEORI TSPGW UNMZH V2I VVN W3M WOQ WOW X3V X3W XYM YFH YOC ZFV ZY1 .3C .55 .GJ 1CY 53G AAYXX ADFPA ADGHP AE3 AFFNX AFUWQ AHRYX BS7 BYPQX CITATION FW0 JF9 JG8 N4W N~M OCUKA ODA ORVUJ OWU P-K R58 T8P X7M XXN ZGI ZXP 8L- ACIJW AWKKM CGR CUY CVF ECM EIF NPM OLW 7X8 5PM ADSXY |
ID | FETCH-LOGICAL-c4052-8a41fc5597fb012af0c1a92274a8b54e34aeef67b24a1986012046045a8acfaa3 |
ISSN | 0025-7974 1536-5964 |
IngestDate | Thu Aug 21 18:24:15 EDT 2025 Fri Jul 11 10:59:31 EDT 2025 Wed Feb 19 02:30:25 EST 2025 Thu Apr 24 23:00:15 EDT 2025 Tue Jul 01 04:19:31 EDT 2025 Fri May 16 03:50:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 26 |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4052-8a41fc5597fb012af0c1a92274a8b54e34aeef67b24a1986012046045a8acfaa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | http://dx.doi.org/10.1097/MD.0000000000007285 |
PMID | 28658124 |
PQID | 1914847533 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5500046 proquest_miscellaneous_1914847533 pubmed_primary_28658124 crossref_primary_10_1097_MD_0000000000007285 crossref_citationtrail_10_1097_MD_0000000000007285 wolterskluwer_health_00005792-201706300-00032 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-June-01 |
PublicationDateYYYYMMDD | 2017-06-01 |
PublicationDate_xml | – month: 06 year: 2017 text: 2017-June-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Medicine (Baltimore) |
PublicationTitleAlternate | Medicine (Baltimore) |
PublicationYear | 2017 |
Publisher | The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved Wolters Kluwer Health |
Publisher_xml | – name: The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved – name: Wolters Kluwer Health |
References | Reid (R16-32-20210309) 2004; 27 Conway (R6-32-20210309) 2015; 136 Grégoire (R9-32-20210309) 2010; 21 Ferlay (R1-32-20210309) 2013; 49 Ligier (R3-32-20210309) 2011; 47 Pornet (R13-32-20210309) 2012; 66 Tromp (R15-32-20210309) 2005; 41 De Camargo Cancela (R14-32-20210309) 2010; 34 Ligier (R4-32-20210309) 2012; 60 Scott (R18-32-20210309) 2005; 41 Stefanuto (R21-32-20210309) 2014; 117 Charlson (R12-32-20210309) 1987; 40 Teppo (R17-32-20210309) 2009; 45 Righini (R5-32-20210309) 2008; 37 Adrien (R19-32-20210309) 2014; 50 |
References_xml | – volume: 136 start-page: 1125 year: 2015 ident: R6-32-20210309 article-title: Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries publication-title: Int J Cancer doi: 10.1002/ijc.29063 – volume: 21 start-page: V184 year: 2010 ident: R9-32-20210309 article-title: Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO. Clinical practice guidelines for diagnosis, treatment and follow-up publication-title: Ann Oncol doi: 10.1093/annonc/mdq185 – volume: 45 start-page: 692 year: 2009 ident: R17-32-20210309 article-title: Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2008.10.012 – volume: 27 start-page: 373 year: 2004 ident: R16-32-20210309 article-title: Comorbidity and early diagnosis of head and neck cancer in a Medicare population publication-title: Am J Prev Med doi: 10.1016/j.amepre.2004.07.018 – volume: 117 start-page: 424 year: 2014 ident: R21-32-20210309 article-title: Delays in treatment of oral cancer: a review of the current literature publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol doi: 10.1016/j.oooo.2013.12.407 – volume: 40 start-page: 373 year: 1987 ident: R12-32-20210309 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 37 start-page: 1229 year: 2008 ident: R5-32-20210309 article-title: Risk factors for cancers of the oral cavity, pharynx (cavity excluded) and larynx publication-title: Presse Med doi: 10.1016/j.lpm.2008.03.010 – volume: 34 start-page: 501 year: 2010 ident: R14-32-20210309 article-title: Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2010.04.012 – volume: 47 start-page: 302 year: 2011 ident: R3-32-20210309 article-title: Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2011.02.013 – volume: 50 start-page: 90 year: 2014 ident: R19-32-20210309 article-title: Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio-economic factors publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2013.10.016 – volume: 41 start-page: 313 year: 2005 ident: R15-32-20210309 article-title: Patient and tumour factors associated with advanced carcinomas of the head and neck publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2004.09.008 – volume: 60 start-page: 131 year: 2012 ident: R4-32-20210309 article-title: Elements of completeness and results of the first year of registration of the “Registre général des cancers de Lille et de sa région” publication-title: Rev Epidemiol Sante Publique doi: 10.1016/j.respe.2011.10.006 – volume: 49 start-page: 1374 year: 2013 ident: R1-32-20210309 article-title: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2012.12.027 – volume: 66 start-page: 982 year: 2012 ident: R13-32-20210309 article-title: Construction of an adaptable European transnational ecological deprivation index: the French version publication-title: J Epidemiol Commun Health doi: 10.1136/jech-2011-200311 – volume: 41 start-page: 396 year: 2005 ident: R18-32-20210309 article-title: The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2004.10.010 |
SSID | ssj0013724 |
Score | 2.3455656 |
Snippet | Head and neck cancers have a very poor prognosis and are common in France. They are subject to various recommendations for early detection and management, but... |
SourceID | pubmedcentral proquest pubmed crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e7285 |
SubjectTerms | Adult Aged Aged, 80 and over Comorbidity Female France Head and Neck Neoplasms - diagnosis Head and Neck Neoplasms - epidemiology Head and Neck Neoplasms - pathology Head and Neck Neoplasms - therapy Humans Incidence Male Middle Aged Neoplasm Staging Observational Study Odds Ratio Registries Young Adult |
Title | Diagnosis and management of head and neck cancers in a high-incidence area in France: A population-based study |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-201706300-00032 https://www.ncbi.nlm.nih.gov/pubmed/28658124 https://www.proquest.com/docview/1914847533 https://pubmed.ncbi.nlm.nih.gov/PMC5500046 |
Volume | 96 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF1FrYSQEOLecKkWiTfjgDdrO-atbQJVRdsH2tI3a-yshWlwqiQWUv-X_2Bmd72Jm4IoeYgSry-R52R3ZjxnDmNvMEQOSDrEz0NJlByIfOgrjHnyQIGQYRxr-tjhUbR_Kg_Ow_NO59dK1VK9yHr51Y28kv-xKm5DuxJL9haWdSfFDfgZ7YvvaGF8_ycbD02dXGn6LP9wlSzWA9RdWL1K5RdU25UTVbesPPCoRbFPOXatJ-rBjNiSldHYsFT1S6fr5dM6N15pQ9vIP9mH8uSi7sJkUZqKXZdX-FSXVzCzRZOV8s9wJcKw3DvqOd9ZfSd46mnveFJq3suBG_0MdQUmnV4TZwyvtOcGd0HLI3lf8KpG_rvJXATxssKq13DfKA84nc17jgSgve6vU6oUmHuWKWAIWc2c6ZGoqc5c0HMVSl23WGBanjcxyj_NDG80cy2Sxep8rWJhFIPs4u--r60spmPx4dA0vLSv5dGtlt00FMaJ8IXuTtQ35P0-egqbAqMZnI43j89Go-HycVcspNMWxh_ftMdK4nc3XLHtQq3FRevlvfd-mht6oe_niv908oDdt4EP3zEofsg6qnrE7jQoeswqB2aOqOVLMPNpwQnMejOBmVsw87LiwNtg5gRmGjBg_sB3-HUocw3lJ-z04-hkb9-3YiB-jjEFrtoggyKn-LfI0KmC4n0eQCJELGGQhVL1JShVRHEmJATJICJSuIwwYIEB5AVA_ynbqKaV2mJcRiIpYgiDMSSyiMYZGmtcDDIMnrJBVkCXieb-prntlE-CLZO0qdg4HKbXjdJlb91Bl6ZRzN93f90YLsUJnZ7SQaWm9TylhovoMmIY1mXPjCHdCYlGTh55l8UtE7sdqFl8e6Qqv-mm8SEpn8ioy_wWGFJDt07_BNnnt9z_Bbu7_Ku_ZBuLWa1eodu-yLZ1umvbQv835WPl2A |
linkProvider | Ovid |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dj5QwEG_MXaImF-O3-FkTw5OoQKFgsg-bhXM9j9Vk9_R8IkNpc5vTsjn29N-3U1i89aKJvEBo4YGZdn7DzPyGkBfGRfaxdYgnIoYlORB7EErj8whfQsAizm35WDGLp0fs4Dg67rMtsBYGq8_a1Ss82X0aL7AfDjqGi9HB3J3lX-Yj7U7mk9FX99P4XW7_U2OWhJuNmh9q7Y5nNv8q4mlgdADpYcKuejo0W_VuHAXcLODdj5_zPPsdb-ABG5q7Goi94SdK-esi6zgO-4MH2Hb5og27BEwv51fu_Www9t2e2tT3CwZs_ya50SNPOu5U5Ra5IvVtcrXoY-t3iM66rLtlS0HX9PuQF0MbRc2WXdvbWopTKlBVzlq61BQoEh57-MfedielYFAoDtiOHfItHdPV0CPMQ5tZU0tpe5cc7eeLydTruzF4woA6s20C85VAB0RVxqqBeiN8SAPj1UJSRUyGDKRUMa8CBn6axFiVy2KDGCEBoQDCe2RHN1o-IJTFQao4RH4NKVNxXRlh1SqpDHqtkkqBQ4LN9y1FT1WOHTO-lZuQeZGVfwrFIS-Hh1YdU8e_pz_fCK40KwrDJKBlc96WyHhnbLbBwQ653wlyeCHW8SIkcgjfEvEwAdm6t0f08sSydkeRrdR1iLelDGVX71r-TWUf_uf8Z-TadFEclofvZx8ekes42mW2PSY767Nz-cRgqHX1tF8AvwAbFQ4p |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFD7ULRRBxLvxOoLkyYiZTG5CHpZN1lrdbWFbrU_hJJnBpZos3a3iv3fO5KJrRTAvCZlJCJnJnO_knPN9AM-1i-ySdIhT-oJKcjBw0JPa5yldiVz4YWjKx2bzYP9EHJz6pzvQR0yp-Gy9ekk7s0zTAcnhkF94nBws7Mliknyy59nHRTK3j8ZvMvObmpIk7KN0mvyw06T5pjZ2epj0_IyztCUp7LaQR_4V2I0iDeRHsHv4IcvSX3GHkItB5FVD7Z6n6O-32bZllwDq5TzLa98bioGvz0wK_G-GbHoDrncIlI3bKXMTdmR9C_ZmXYz9NtRpm323XDOsK_Z1yI9hjWJ66a7M6VqWZ6ykKXO-ZsuaISPiY4f-3BuVUoYajVKDUe6Qr9mYrQatMIdsZ8UMte0dOJlmx5N9p1NlcEoN7vTyicJVJTkiqtDWDdWr0sWYa-8Wo8IX0hMopQrCggt0Y_2WXU7BV-FjhKVC9O7CqG5qeR-YCHisQvTdCmOhgqrQ4LFSUaFRbBEVCi3g_fvNy46ynJQzvuR96HyW5n8OigUvhotWLWPHv7s_6wcu118WhUuwls3FOifmO227NR624F47kMMNqZ6XoJEF4dYQDx2ItXu7pV5-NuzdPklQiMACZ2sy5G3dq3k-P4y5Xr6I2chrC_89_uA_-z-FPf1B5O_fzt89hKvU2Ca4PYLR5vxCPtZQalM86eb_T1E8D70 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis+and+management+of+head+and+neck+cancers+in+a+high-incidence+area+in+France%3A+A+population-based+study&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Guizard%2C+Anne-Valerie+N.&rft.au=Dejardin%2C+Olivier+J.&rft.au=Launay%2C+Ludivine+C.&rft.au=Bara%2C+Simona&rft.date=2017-06-01&rft.pub=The+Authors.+Published+by+Wolters+Kluwer+Health%2C+Inc.+All+rights+reserved&rft.issn=0025-7974&rft.volume=96&rft.issue=26&rft.spage=e7285&rft.epage=e7285&rft_id=info:doi/10.1097%2FMD.0000000000007285&rft.externalDocID=00005792-201706300-00032 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon |